Kesari Achyut Narayan, Kesari Shweta, Singh Santosh Kumar, Gupta Rajesh Kumar, Watal Geeta
Alternative Therapeutics Unit, Drug Development Division, Medicinal Research Lab, Department of Chemistry, University of Allahabad, Allahabad 211002, India.
J Ethnopharmacol. 2007 Jun 13;112(2):305-11. doi: 10.1016/j.jep.2007.03.023. Epub 2007 Mar 24.
Diabetes is often accompanied by lipid abnormalities, which contribute significantly to cardiovascular morbidity and mortality in diabetic patients. Previously, we have demonstrated potent hypoglycemic activity of lyophilized aqueous extract of Murraya koenigii leaves in normal and alloxan induced diabetic rabbits for short duration of 6 h. In this study, we examined the effect of 1 month oral administration of Murraya koenigii aqueous leaves extract in normal and STZ induced severe diabetic rats, at the dose of 300 mg/kg bw, on various biochemical parameters, viz., fasting blood glucose (FBG), total cholesterol (TC), HDL-cholesterol (HDL), triglyceride (TG), alkaline phosphatase (ALKP), serum glutamate oxaloacetate and pyruvate transaminases (SGOT and SGPT) and serum creatinine. In case of diabetic animals fasting blood glucose (FBG) levels of treated animals reduced by 48.2% after 30 days treatment with the aqueous leaves extract. A fall of 19.2 and 30.8% in TC and 22.97 and 37.1% in TG levels were also observed in the case of treated normal as well as diabetic rats, respectively. Feeding the extract increased the HDL-cholesterol level by 16 and 29.4% in normal and diabetic rats, respectively, as compared with their initial values. In the normal rats after 1 month of oral administration of the extract SGOT and SGPT levels were decreased by 21.7 and 25.0%. Serum alkaline phosphatase values of the treated normal animals were also reduced by 33% while negligible change was observed in the normal control animals. In the case of diabetic rats, SGOT and SGPT levels were reduced by 36.7 and 32.2%, respectively, whereas ALKP levels decreased by 39.7% after 1 month oral administration of the extract. The serum creatinine levels decrease in normal as well as in the diabetic animals by 17.75 and 18.2%, respectively, as compared to initial values. In the diabetic control animals the urinary sugar remains at +4 level but there was a decrease of 75% in urine sugar in the case of treated diabetic rats. This indicates that the aqueous extract of Murraya koenigii has favorable effect in bringing down the severity of diabetes.
糖尿病常伴有脂质异常,这在很大程度上导致了糖尿病患者的心血管发病率和死亡率。此前,我们已证明,九里香叶冻干水提取物在正常和四氧嘧啶诱导的糖尿病兔中具有显著的降糖活性,作用时长为6小时。在本研究中,我们以300mg/kg体重的剂量,对正常和链脲佐菌素诱导的重度糖尿病大鼠口服给予九里香叶水提取物1个月,观察其对各种生化参数的影响,即空腹血糖(FBG)、总胆固醇(TC)、高密度脂蛋白胆固醇(HDL)、甘油三酯(TG)、碱性磷酸酶(ALKP)、血清谷氨酸草酰乙酸转氨酶和丙酮酸转氨酶(SGOT和SGPT)以及血清肌酐。对于糖尿病动物,经叶水提取物治疗30天后,治疗组动物的空腹血糖(FBG)水平降低了48.2%。在治疗的正常大鼠和糖尿病大鼠中,TC水平分别下降了19.2%和30.8%,TG水平分别下降了22.97%和37.1%。与初始值相比,喂食提取物使正常大鼠和糖尿病大鼠的高密度脂蛋白胆固醇水平分别提高了16%和29.4%。在正常大鼠中,口服提取物1个月后,SGOT和SGPT水平分别下降了21.7%和25.0%。治疗组正常动物的血清碱性磷酸酶值也降低了33%,而正常对照组动物观察到的变化可忽略不计。对于糖尿病大鼠,口服提取物1个月后,SGOT和SGPT水平分别降低了36.7%和32.2%,而ALKP水平降低了39.7%。与初始值相比,正常动物和糖尿病动物的血清肌酐水平分别下降了17.75%和18.2%。在糖尿病对照动物中,尿糖保持在+4水平,但在治疗的糖尿病大鼠中,尿糖下降了75%。这表明九里香叶水提取物在降低糖尿病严重程度方面具有良好的效果。